Dialog window

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

Dialog window

Jennifer Porter, BA Psychology, MBA – President & CEO

​Having started at Focal Point Research in 2011, Jenn has been fully engaged in the company and since day one, has leveraged her MBA and interest in the regulated products industries to grow her passion for the business and services offered. 

Jenn has excelled at building on initial conversations with a variety of companies from all industries seeking regulatory and quality assurance services. She has developed strong relationships with each client, offering each one a unique opportunity to have the Focal Point Research team help them develop successful strategies and bring products to market, while ensuring their compliance needs are being fulfilled. 

Jenn has not only been a leader internally, but a key contact for all clients and in 2021, Jenn was the obvious choice to lead Focal Point Research into the future as the successor to company founder, Rob Fichtner.

Jennifer balances her career by honouring her wanderlust, spending her leisure time golfing, and enjoying the outdoors with her loving dog.

(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
      • Natural Health Products
      • Topical OTC Drugs
      • Medical Devices
      • Consumer Products
      • FDA Consulting
    • Health Canada Consultants
      • Regulatory Affairs
      • Pharmacovigilance Services
      • MoCRA
      • Ingredient Compliance
      • CEPA
  • Innovation
  • Articles
  • Contact
Select Page
Health Canada Announces the Creation of a New Medical Devices Directorate

Health Canada Announces the Creation of a New Medical Devices Directorate

by Jenn Porter | Dec 18, 2019 | Canadian Regulatory, Medical Devices, Research/Science/Technology, Uncategorized

Health Canada has announced the creation of a new Medical Devices Directorate (MDD). This was done in order to account for and accurately reflect the current medical device industry, which has evolved drastically over the past several years. The new Directorate will...
European Commission Adopts Major Changes to Titanium Dioxide Classification

European Commission Adopts Major Changes to Titanium Dioxide Classification

by Jenn Porter | Nov 27, 2019 | Canadian Regulatory, Cosmetics, European Regulatory, Natural Health Products, Research/Science/Technology

Early last month the European Commission (EC) adopted the 14th adaptation to technical progress (ATP) of the Classification and Labelling (CLP) Regulation. Within this adaptation are 28 proposed changes to the harmonised classification and labelling of substances. One...
Everything You Need To Know About Animal Testing Bans: Where They Stand And Where They Are Headed

Everything You Need To Know About Animal Testing Bans: Where They Stand And Where They Are Headed

by Jenn Porter | Nov 12, 2019 | Canadian Regulatory, Cosmetics, Natural Health Products, Research/Science/Technology, U.S. Regulatory

Animal testing is, quite possibly, one of the most controversial and widely debated ethical issues in the cosmetic, personal care and healthcare industries. It is an issue that has gained an immense amount of traction in recent years, and rightly so, with numerous...
Feeling Blue: Can Blue Light Damage Your Skin?

Feeling Blue: Can Blue Light Damage Your Skin?

by Jenn Porter | Oct 22, 2019 | Canadian Regulatory, Cosmetics, Medical Devices, Natural Health Products, Research/Science/Technology, U.S. Regulatory

While the general public is largely aware of the harmful effects ultraviolet (UV) light can have on our bodies, as well as the basic measures that should be taken to protect ourselves against such effects, the dangers surrounding blue light seem to go relatively left...
EPA’s Proposed Prioritization of Chemical Substances

EPA’s Proposed Prioritization of Chemical Substances

by Jenn Porter | Oct 2, 2019 | Canadian Regulatory, OTC Drugs, Research/Science/Technology, U.S. Regulatory

Last month the United States Environmental Protection Agency (EPA) released a list of 20 chemical substances that they proposed be designated as High Priority Substances. The list, which was released as required under the Toxic Substances Control Act (TSCA), is...
Update on Titanium Dioxide in Sunscreens

Update on Titanium Dioxide in Sunscreens

by Jenn Porter | Sep 12, 2019 | Canadian Regulatory, Cosmetics, Research/Science/Technology, U.S. Regulatory, Uncategorized

Currently, the Canadian Natural Health Products Ingredients Database (NHPID) lists Titanium dioxide (TiO2) as an opacifying agent and color additive for topical use, but is NOT permitted in sunscreens for these uses. However, according to Cosmetics Alliance Canada,...
« Older Entries
Next Entries »

Recent Posts

  • 📢 FDA Modernization in Action: The Bemotrizinol Proposal & The Future of OTC Monograph Reform
  • Illinois Proposed Ban on Nonbiodegradable Plastic Glitter
  • Washington State TFCA Sell-Through Period Expires December 31
  • Health Canada Proposed Updates to the Cosmetic Ingredient Hotlist
  • Updates on Amendment and Notification Applications for Site Licences

Recent Comments

    Archives

    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • June 2025
    • May 2025
    • March 2025
    • October 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • December 2023
    • November 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • January 2023
    • December 2022
    • November 2022
    • July 2022
    • June 2022
    • April 2022
    • March 2022
    • October 2021
    • July 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • California Cosmetic Regulations
    • California Office of Environmental Health Hazard Assessment
    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetic Ingredient Hotlist
    • Cosmetics
    • Cosmetics
    • Environment and Climate Change Canada
    • European Regulatory
    • Events/Company Updates
    • FDA
    • Federal Plastics Registry
    • Health Canada Updates
    • Importation of NHPs
    • Innovation
    • Medical Device
    • Medical Devices
    • MoCRA
    • Natural Health Products
    • New Mexico
    • OTC Drugs
    • Our View
    • Prop 65
    • Research/Science/Technology
    • Toxic-Free Cosmetics Act
    • U.S. Regulatory
    • U.S. State Updates
    • Uncategorized
    Copyright © 2025 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY